Recurrent Middle Ear Cancer: Case Report
Journal Title: Diseases & Research - Year 2024, Vol 4, Issue 1
Abstract
Background: Middle ear cancer is clinically uncommon, representing approximately 1.5% of ear malignancies and 0.03% to 0.06% of all cancers. Recurrent cases of middle ear cancer are particularly rare. This report discusses a patient with middle ear cancer who experienced invasive growth into surrounding tissues and developed a large cancerous ulcer post-resection. Case Summary: A 72-year-old male underwent a subtotal resection of the right temporal bone in February 2021, diagnosed with squamous cell carcinoma of the middle ear. Regrettably, he did not receive follow-up medical care after surgery. In June 2022, he returned to the hospital with complaints of pus and bleeding from a mass behind his ear. Further examinations led to a diagnosis of recurrent middle ear cancer with extensive local infiltration. We initiated a combination treatment comprising targeted therapy, chemotherapy, radiotherapy, and local application of rhGM-CSF. The patient showed remarkable sensitivity to this treatment plan, evidenced by a significant reduction in the mass and discharge behind the ear within a week. After two cycles of combined targeted therapy and chemotherapy, the treatment's effectiveness was assessed as PR (partial response) via magnetic resonance imaging. As of August 2023, the patient remains in stable condition. Conclusion: For such a recurrent middle ear cancer with giant cancerous ulcer, we suggest do not neglect local treatment while giving anti-tumor treatment.
Authors and Affiliations
Hui Ma, Hongxun Ye, Fei Gao
Keywords
Related Articles
- EP ID EP740222
- DOI 10.54457/DR.202401001
- Views 14
- Downloads 1
Roles of Toll-like Receptor 3 in Intrauterine Transmission of Hepatitis B Virus in Mothers with High Viral Load
Backgrounds Despite passive and active immunization, perinatal mother-to-infant transmission (MTIT) of hepatitis B virus (HBV) still occurs in women with high levels of viremia. Thus, understanding the mechanisms of MTIT...
HBeAg Negativity is Associated with a Higher Risk of Liver-Related Death in Patients with Chronic Hepatitis B Related Liver Cirrhosis
Background and aims Few studies reported the association between the survival of patients with chronic hepatitis B (CHB)-related liver cirrhosis (LC) and hepatitis B e antigen (HBeAg) state. Methods Three hundred and ni...
Interferons in Colorectal Cancer Pathogenesis and Therapy
As key modulators of the immune response, interferons play critical roles following infection and during the pathogenesis of cancer. The idea that these cytokines might be developed as new therapies emerged soon after th...
Updating CAR-T Cell Immunotherapy for Liquid and Solid Tumor
According to the GLOBOCAN 2020 report, there is still a 50% mortality rate observed in cancer patients despite the availability of various innovative cancer therapies. This highlights the need for specific therapies that...
An Analysis of Gut Bacterial and Fungal Community Interactions in Saxifraga stolonifera Curt.-Treated Mice
Backgrounds Saxifraga stoloniferaCurt. is valued for its great medicinal potentials, especially for anti-inflammatory activity. The gut microbiome is gradually regarded as a pivotal part that contributes to the therapeut...